EBCC 2024 | The future of AI in managing breast cancer

Tim Rattay, MBChB, PhD, FRCS, University of Leicester, Leicester, UK, discusses the future of artificial intelligence (AI) in managing breast cancer. The PRE-ACT project is creating ‘explainable AI’ that provides outputs that aid patient and clinician decision making, not replace it. This interview took place at the 14th European Breast Cancer Conference (EBCC) in Milan, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.